News And Information From Kexing Biopharm On The Drug Bevacizumab

Home / News / News and Inn...

News

Here, we share with you the freshest corporate trends, the most informative industry information, the richest multimedia resources, and more highlights, so stay tuned.

Jul 13,2023

China's first infliximab biosimilar drug ready for export, Kexing Biopharm initiated drug registration in 17 countries

Following the NMPA's approval for the marketing application of infliximab biosimilar (CMAB008) on July 14, Kexing Biopharm quickly started working on an overseas sales plan for the drug.

READ MORE >>
Jul 13,2023

China's first infliximab biosimilar drug ready for export, Kexing Biopharm initiated drug registration in 17 countries

Following the NMPA's approval for the marketing application of infliximab biosimilar (CMAB008) on July 14, Kexing Biopharm quickly started working on an overseas sales plan for the drug.

READ MORE >>

Prev 1 2 3 4 5 Next

Home
Kexing Biopharm
Global Business
R&D and Innovation
Our Medicines
Quality Control
ESG
News
Contact
- Contact Us
- Join Us